GoodRx (GDRX)
(Delayed Data from NSDQ)
$6.91 USD
-0.17 (-2.40%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.90 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
GDRX 6.91 -0.17(-2.40%)
Will GDRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GDRX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GDRX
GoodRx (GDRX) Reports Q2 Earnings: What Key Metrics Have to Say
GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue Estimates
GDRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates
Unveiling GoodRx (GDRX) Q2 Outlook: Wall Street Estimates for Key Metrics
Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates
Other News for GDRX
GDRX Makes Notable Cross Below Critical Moving Average
GoodRx to Participate in Upcoming Investor Conferences
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
RBC Capital Keeps Their Buy Rating on GoodRx Holdings (GDRX)
Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc ...